Oncoinvent ASA (OSL:ONCIN)
Norway · Delayed Price · Currency is NOK 67.00
0.00 (0.00%)
Oct 23, 2026, 4:12 PM CEST
Oncoinvent ASA Market Cap
Oncoinvent ASA has a market cap or net worth of 410.6 million as of October 23, 2026. It is the 31,005th most valuable company in the world and the 217th biggest in Norway.
Market Cap
410.60M
Enterprise Value
305.87M
Revenue
24.31M
Global Rank
Country Rank
#217 Norway
PE Ratio
n/a
ChartMarket Cap Chart
Since October 30, 2025, Oncoinvent ASA's market cap has increased from 186.40M to 410.60M, an increase of 120.28%. That is a compound annual growth rate of 123.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 410.60M | 86.73% |
| Dec 30, 2025 | 219.89M | 17.96% |
| Oct 30, 2025 | 186.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 3.16B |
| Thor Medical ASA | 1.77B |
| ArcticZymes Technologies ASA | 1.04B |
| Nykode Therapeutics AS | 1.03B |
| Lytix Biopharma ASA | 612.12M |
| Zelluna ASA | 536.00M |
| SoftOx Solutions AS | 288.28M |
| Aqua Bio Technology ASA | 71.09M |